Immunohistochemical analysis of p16 expression in uterine smooth muscle tumors

European Journal of Gynaecological Oncology

Volumn 32, Issue 5, 2011, Pages 513-515

  Hakverdi, S ^a   Gungoren A ^a   Yaldiz, M ^a   Hakverdi, A U ^a   Toprak, S ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Leiomyoma; Leiomyosarcoma; p16 expression; Uterus

Indexed keywords

PROTEIN P16; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MYOMETRIUM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; TISSUE DISTRIBUTION; TISSUE SECTION; UTERUS MYOMA; UTERUS TUMOR;

ADULT; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; MYOMETRIUM; TUMOR SUPPRESSOR PROTEINS; UTERINE NEOPLASMS;

EID: 81255198835     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zaloudek C.J., Hendrickson C.J.: "Mesenchymal tumors of the uterus. In: Kurman R.J. (ed.). Blaustein's Pathology of the Female Genital Tract". New York, Springer Verlag, 2002, 561.
2. Vollenhoven B.J., Lawrence A.S., Healy D.L.: "Uterine fibroids: a clinical review". Br. J. Obstet. Gynecol., 1990, 97, 285.
3. O'Neill C.J., McBride H.A., Connolly L.E., McCluggage W.G.: "Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumors of uncertain malignant potential". Histopathology, 2007, 50, 851.
4. Tavasosoli F.A., Devilee P.: "Pathology and Genetics of Tumours of the Breast and Female Genital Organs". Lyon, IARC Press, 2003.
5. Bodner-Adler B., Bodner K., Czerwenka K., Kimbergerc O., L. Sepp, M. Klaus: "Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis". Gynecol. Oncol., 2005, 96, 62.
6. Amada S., Nakano H., Tsuneyoshi M.: "Leiomyosarcoma versus bizzare and celluler leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins". Int. J. Gynecol. Pathol., 1995, 14, 134.
7. Esposito N.N., Hunt J.L., Bakker A., Jones M.W.: "Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors". Am. J. Surg. Pathol., 2006, 30, 97.
8. Kamb A., Grius N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tartigion S.V. et al.: "A cell cycle regulator potentially involved in genesis of many tumor types". Science (Washington DC), 1994, 264, 436. (Pubitemid 24178909)
9. Van de Putte G., Holm R., Lie A.K., Trope C.G., Kristensen G.B.: "Expression of p27, p21 and p16 protein in early squamous cervical cancer and its relation to prognosis". Gynecol. Oncol., 2003, 89,140.
10. Rocco J.W., Sidransky D.: "p16(MTS-1/CDKN2/INK4a) in cancer progression". Exp. Cell Res., 2001, 264, 42.
11. Bell S.W., Kempson R.L., Hendrikson M.R.: "Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases". Am. J. Surg. Pathol., 1994, 18, 535.
12. Sharpless N.E.: "INK4a/ARF: a multifunctional tumor suppressor locus." Mutat. Res., 2005, 576, 22.
13. Feakins R.M., Nickols C.D., Bidd H., Walton S.J.: "Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocaecinoma and its lymp node metastases: relationship with pathological features and survival". Hum. Pathol., 2003, 34, 1276.
14. Kalof A.N., Cooper K.: "p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia". Adv Anat Pathol., 2006, 13, 190.
15. Toledo G., Oliva E.: "Smooth muscle tumors of the uterus: a practical approach". Arch. Pathol. Lab. Med., 2008, 595.
16. Al-Naffussi A.: "Uterine smooth-muscle tumours: practical approach to diagnosis". Curr. Diagn. Pathol., 2004, 10, 140.
17. D'Angelo E., Prat J.: "Uterine sarcomas: a review". Gynecol. Oncol., 2010, 116, 131.